
09/05/2025
In this week’s episode of the Eye on the Cure podcast, Dr. George Magrath, CEO of Opus Genetics, joins host Ben Shaberman to discuss the company’s journey and exciting progress in advancing gene therapies for multiple inherited retinal diseases — including those caused by mutations in LCA5, BEST1, RHO, RDH12, MERTK, NMNAT1, and CNGB1.
Tune in to learn more about how Opus is driving innovation for the vision loss community — and don’t forget to share this episode with friends, family, and advocates who want to stay informed. https://bit.ly/41y7QGU
Image Description: Dark blue background with Foundation Fighting Blindness logo in the top left and Eye on the Cure Podcast logo in the top right. Teal half circle at the top center with "Ep. 91" inside. Below, text reads, "Listen to the latest podcast episode out now. September 5, 2025." To the left is Ben Shaberman with "Ben Shaberman, Host" beneath. To the right is Dr. George Magrath with " Dr. George Magrath, Guest" below.